Literature DB >> 31697812

Clinical utility of targeted next-generation sequencing-based screening of peripheral blood in the evaluation of cytopenias.

Vignesh Shanmugam1, Aric Parnes2, Rajeshwari Kalyanaraman3, Elizabeth A Morgan1, Annette S Kim1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31697812     DOI： 10.1182/blood.2019001610

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Mutational analysis of hematologic neoplasms in 164 paired peripheral blood and bone marrow samples by next-generation sequencing.

Authors:  Fabienne Lucas; Phillip D Michaels; Dahai Wang; Annette S Kim
Journal:  Blood Adv       Date:  2020-09-22

2.  Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients.

Authors:  Jonathan Chiou; Allison Chiou; Rong He; Dong Chen; Constance P Chen; Caroline Spethman; Kurt R Bessonen; Jennifer L Oliveira; Phuong L Nguyen; Kaaren K Reichard; James D Hoyer; Simon D Althoff; Dana J Roh; Mechelle A Miller; Ji Yuan; Horatiu Olteanu; Kebede Begna; Ayalew Tefferi; Hassan Alkhateeb; Mrinal M Patnaik; Mark R Litzow; Aref Al-Kali; David S Viswanatha
Journal:  Blood Cancer J       Date:  2022-01-25       Impact factor: 11.037

3.  Concordance of Peripheral Blood and Bone Marrow Next-Generation Sequencing in Hematologic Neoplasms.

Authors:  Chayanit Jumniensuk; Alexander Nobori; Thomas Lee; T Niroshi Senaratne; Dinesh Rao; Sheeja Pullarkat
Journal:  Adv Hematol       Date:  2022-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.